nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.109	0.168	CbGbCtD
Efavirenz—CYP2C19—Progesterone—uterine cancer	0.0872	0.134	CbGbCtD
Efavirenz—CYP1A2—Progesterone—uterine cancer	0.0805	0.123	CbGbCtD
Efavirenz—CYP2C9—Progesterone—uterine cancer	0.0725	0.111	CbGbCtD
Efavirenz—CYP2D6—Progesterone—uterine cancer	0.0663	0.102	CbGbCtD
Efavirenz—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0637	0.0977	CbGbCtD
Efavirenz—CYP3A4—Progesterone—uterine cancer	0.0422	0.0647	CbGbCtD
Efavirenz—CYP2B6—Doxorubicin—uterine cancer	0.0419	0.0643	CbGbCtD
Efavirenz—CYP1A2—Etoposide—uterine cancer	0.036	0.0553	CbGbCtD
Efavirenz—CYP2D6—Doxorubicin—uterine cancer	0.0202	0.0311	CbGbCtD
Efavirenz—CYP3A4—Etoposide—uterine cancer	0.0189	0.029	CbGbCtD
Efavirenz—CYP3A4—Doxorubicin—uterine cancer	0.0129	0.0197	CbGbCtD
Efavirenz—Hypertension—Etoposide—uterine cancer	0.000233	0.000668	CcSEcCtD
Efavirenz—Diplopia—Doxorubicin—uterine cancer	0.000232	0.000666	CcSEcCtD
Efavirenz—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000231	0.000664	CcSEcCtD
Efavirenz—Chest pain—Etoposide—uterine cancer	0.000229	0.000659	CcSEcCtD
Efavirenz—Migraine—Doxorubicin—uterine cancer	0.000228	0.000656	CcSEcCtD
Efavirenz—Affect lability—Doxorubicin—uterine cancer	0.000228	0.000656	CcSEcCtD
Efavirenz—Hypokalaemia—Epirubicin—uterine cancer	0.000228	0.000655	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000228	0.000654	CcSEcCtD
Efavirenz—Discomfort—Etoposide—uterine cancer	0.000227	0.000651	CcSEcCtD
Efavirenz—Breast disorder—Epirubicin—uterine cancer	0.000227	0.000651	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000226	0.000648	CcSEcCtD
Efavirenz—Nasopharyngitis—Epirubicin—uterine cancer	0.000224	0.000644	CcSEcCtD
Efavirenz—Hypersensitivity—Dactinomycin—uterine cancer	0.000224	0.000643	CcSEcCtD
Efavirenz—Confusional state—Etoposide—uterine cancer	0.000222	0.000637	CcSEcCtD
Efavirenz—Muscular weakness—Epirubicin—uterine cancer	0.000221	0.000635	CcSEcCtD
Efavirenz—Mood swings—Doxorubicin—uterine cancer	0.00022	0.000631	CcSEcCtD
Efavirenz—Abdominal distension—Epirubicin—uterine cancer	0.000218	0.000626	CcSEcCtD
Efavirenz—Ataxia—Doxorubicin—uterine cancer	0.000218	0.000626	CcSEcCtD
Efavirenz—Asthenia—Dactinomycin—uterine cancer	0.000218	0.000626	CcSEcCtD
Efavirenz—Blood creatinine increased—Doxorubicin—uterine cancer	0.000217	0.000624	CcSEcCtD
Efavirenz—Asthma—Epirubicin—uterine cancer	0.000217	0.000622	CcSEcCtD
Efavirenz—Thrombocytopenia—Etoposide—uterine cancer	0.000215	0.000618	CcSEcCtD
Efavirenz—Tachycardia—Etoposide—uterine cancer	0.000215	0.000616	CcSEcCtD
Efavirenz—Skin disorder—Etoposide—uterine cancer	0.000214	0.000613	CcSEcCtD
Efavirenz—Hyperhidrosis—Etoposide—uterine cancer	0.000212	0.00061	CcSEcCtD
Efavirenz—Pancreatitis—Epirubicin—uterine cancer	0.000212	0.00061	CcSEcCtD
Efavirenz—Hypokalaemia—Doxorubicin—uterine cancer	0.000211	0.000606	CcSEcCtD
Efavirenz—Breast disorder—Doxorubicin—uterine cancer	0.00021	0.000602	CcSEcCtD
Efavirenz—Anorexia—Etoposide—uterine cancer	0.00021	0.000602	CcSEcCtD
Efavirenz—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000209	0.0006	CcSEcCtD
Efavirenz—Diarrhoea—Dactinomycin—uterine cancer	0.000208	0.000597	CcSEcCtD
Efavirenz—Nasopharyngitis—Doxorubicin—uterine cancer	0.000207	0.000596	CcSEcCtD
Efavirenz—Pancytopenia—Epirubicin—uterine cancer	0.000206	0.000591	CcSEcCtD
Efavirenz—Muscular weakness—Doxorubicin—uterine cancer	0.000205	0.000588	CcSEcCtD
Efavirenz—Abdominal distension—Doxorubicin—uterine cancer	0.000202	0.00058	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000201	0.000578	CcSEcCtD
Efavirenz—Asthma—Doxorubicin—uterine cancer	0.0002	0.000576	CcSEcCtD
Efavirenz—Photosensitivity reaction—Epirubicin—uterine cancer	0.000198	0.000568	CcSEcCtD
Efavirenz—Paraesthesia—Etoposide—uterine cancer	0.000197	0.000567	CcSEcCtD
Efavirenz—Pancreatitis—Doxorubicin—uterine cancer	0.000197	0.000564	CcSEcCtD
Efavirenz—Dyspnoea—Etoposide—uterine cancer	0.000196	0.000563	CcSEcCtD
Efavirenz—Hyperglycaemia—Epirubicin—uterine cancer	0.000195	0.000561	CcSEcCtD
Efavirenz—Somnolence—Etoposide—uterine cancer	0.000195	0.000561	CcSEcCtD
Efavirenz—Pneumonia—Epirubicin—uterine cancer	0.000194	0.000558	CcSEcCtD
Efavirenz—Drowsiness—Epirubicin—uterine cancer	0.000193	0.000555	CcSEcCtD
Efavirenz—Infestation NOS—Epirubicin—uterine cancer	0.000193	0.000555	CcSEcCtD
Efavirenz—Infestation—Epirubicin—uterine cancer	0.000193	0.000555	CcSEcCtD
Efavirenz—Vomiting—Dactinomycin—uterine cancer	0.000193	0.000555	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000192	0.00055	CcSEcCtD
Efavirenz—Rash—Dactinomycin—uterine cancer	0.000191	0.00055	CcSEcCtD
Efavirenz—Decreased appetite—Etoposide—uterine cancer	0.000191	0.000549	CcSEcCtD
Efavirenz—Pancytopenia—Doxorubicin—uterine cancer	0.00019	0.000547	CcSEcCtD
Efavirenz—Renal failure—Epirubicin—uterine cancer	0.00019	0.000545	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Etoposide—uterine cancer	0.00019	0.000545	CcSEcCtD
Efavirenz—Fatigue—Etoposide—uterine cancer	0.00019	0.000544	CcSEcCtD
Efavirenz—Neuropathy peripheral—Epirubicin—uterine cancer	0.000189	0.000544	CcSEcCtD
Efavirenz—Jaundice—Epirubicin—uterine cancer	0.000188	0.000541	CcSEcCtD
Efavirenz—Pain—Etoposide—uterine cancer	0.000188	0.00054	CcSEcCtD
Efavirenz—Constipation—Etoposide—uterine cancer	0.000188	0.00054	CcSEcCtD
Efavirenz—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000186	0.000535	CcSEcCtD
Efavirenz—Sweating—Epirubicin—uterine cancer	0.000185	0.000532	CcSEcCtD
Efavirenz—Haematuria—Epirubicin—uterine cancer	0.000184	0.000529	CcSEcCtD
Efavirenz—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000183	0.000526	CcSEcCtD
Efavirenz—Hepatobiliary disease—Epirubicin—uterine cancer	0.000183	0.000525	CcSEcCtD
Efavirenz—Sinusitis—Epirubicin—uterine cancer	0.000181	0.000521	CcSEcCtD
Efavirenz—Feeling abnormal—Etoposide—uterine cancer	0.000181	0.00052	CcSEcCtD
Efavirenz—Hyperglycaemia—Doxorubicin—uterine cancer	0.000181	0.000519	CcSEcCtD
Efavirenz—Nausea—Dactinomycin—uterine cancer	0.00018	0.000518	CcSEcCtD
Efavirenz—Pneumonia—Doxorubicin—uterine cancer	0.00018	0.000516	CcSEcCtD
Efavirenz—Gastrointestinal pain—Etoposide—uterine cancer	0.00018	0.000516	CcSEcCtD
Efavirenz—Infestation—Doxorubicin—uterine cancer	0.000179	0.000513	CcSEcCtD
Efavirenz—Drowsiness—Doxorubicin—uterine cancer	0.000179	0.000513	CcSEcCtD
Efavirenz—Infestation NOS—Doxorubicin—uterine cancer	0.000179	0.000513	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000177	0.000509	CcSEcCtD
Efavirenz—Renal failure—Doxorubicin—uterine cancer	0.000176	0.000505	CcSEcCtD
Efavirenz—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000175	0.000503	CcSEcCtD
Efavirenz—Urticaria—Etoposide—uterine cancer	0.000175	0.000501	CcSEcCtD
Efavirenz—Jaundice—Doxorubicin—uterine cancer	0.000174	0.0005	CcSEcCtD
Efavirenz—Rhinitis—Epirubicin—uterine cancer	0.000174	0.000499	CcSEcCtD
Efavirenz—Abdominal pain—Etoposide—uterine cancer	0.000174	0.000499	CcSEcCtD
Efavirenz—Body temperature increased—Etoposide—uterine cancer	0.000174	0.000499	CcSEcCtD
Efavirenz—Hepatitis—Epirubicin—uterine cancer	0.000173	0.000498	CcSEcCtD
Efavirenz—Hypoaesthesia—Epirubicin—uterine cancer	0.000173	0.000496	CcSEcCtD
Efavirenz—Sweating—Doxorubicin—uterine cancer	0.000171	0.000492	CcSEcCtD
Efavirenz—Urinary tract disorder—Epirubicin—uterine cancer	0.000171	0.000492	CcSEcCtD
Efavirenz—Oedema peripheral—Epirubicin—uterine cancer	0.000171	0.000491	CcSEcCtD
Efavirenz—Haematuria—Doxorubicin—uterine cancer	0.00017	0.000489	CcSEcCtD
Efavirenz—Connective tissue disorder—Epirubicin—uterine cancer	0.00017	0.000489	CcSEcCtD
Efavirenz—Urethral disorder—Epirubicin—uterine cancer	0.00017	0.000488	CcSEcCtD
Efavirenz—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000169	0.000486	CcSEcCtD
Efavirenz—Sinusitis—Doxorubicin—uterine cancer	0.000168	0.000482	CcSEcCtD
Efavirenz—Visual impairment—Epirubicin—uterine cancer	0.000167	0.00048	CcSEcCtD
Efavirenz—Erythema multiforme—Epirubicin—uterine cancer	0.000164	0.000471	CcSEcCtD
Efavirenz—Eye disorder—Epirubicin—uterine cancer	0.000162	0.000465	CcSEcCtD
Efavirenz—Hypersensitivity—Etoposide—uterine cancer	0.000162	0.000465	CcSEcCtD
Efavirenz—Tinnitus—Epirubicin—uterine cancer	0.000162	0.000464	CcSEcCtD
Efavirenz—Flushing—Epirubicin—uterine cancer	0.000161	0.000462	CcSEcCtD
Efavirenz—Cardiac disorder—Epirubicin—uterine cancer	0.000161	0.000462	CcSEcCtD
Efavirenz—Rhinitis—Doxorubicin—uterine cancer	0.000161	0.000462	CcSEcCtD
Efavirenz—Hepatitis—Doxorubicin—uterine cancer	0.00016	0.000461	CcSEcCtD
Efavirenz—Hypoaesthesia—Doxorubicin—uterine cancer	0.00016	0.000459	CcSEcCtD
Efavirenz—Urinary tract disorder—Doxorubicin—uterine cancer	0.000158	0.000455	CcSEcCtD
Efavirenz—Oedema peripheral—Doxorubicin—uterine cancer	0.000158	0.000454	CcSEcCtD
Efavirenz—Asthenia—Etoposide—uterine cancer	0.000158	0.000453	CcSEcCtD
Efavirenz—Connective tissue disorder—Doxorubicin—uterine cancer	0.000158	0.000453	CcSEcCtD
Efavirenz—Angiopathy—Epirubicin—uterine cancer	0.000157	0.000452	CcSEcCtD
Efavirenz—Urethral disorder—Doxorubicin—uterine cancer	0.000157	0.000452	CcSEcCtD
Efavirenz—Immune system disorder—Epirubicin—uterine cancer	0.000157	0.00045	CcSEcCtD
Efavirenz—Mediastinal disorder—Epirubicin—uterine cancer	0.000156	0.000449	CcSEcCtD
Efavirenz—Pruritus—Etoposide—uterine cancer	0.000156	0.000447	CcSEcCtD
Efavirenz—Arrhythmia—Epirubicin—uterine cancer	0.000155	0.000445	CcSEcCtD
Efavirenz—Visual impairment—Doxorubicin—uterine cancer	0.000155	0.000444	CcSEcCtD
Efavirenz—Alopecia—Epirubicin—uterine cancer	0.000153	0.00044	CcSEcCtD
Efavirenz—Erythema multiforme—Doxorubicin—uterine cancer	0.000152	0.000436	CcSEcCtD
Efavirenz—Malnutrition—Epirubicin—uterine cancer	0.000151	0.000434	CcSEcCtD
Efavirenz—Erythema—Epirubicin—uterine cancer	0.000151	0.000434	CcSEcCtD
Efavirenz—Diarrhoea—Etoposide—uterine cancer	0.00015	0.000432	CcSEcCtD
Efavirenz—Eye disorder—Doxorubicin—uterine cancer	0.00015	0.000431	CcSEcCtD
Efavirenz—Tinnitus—Doxorubicin—uterine cancer	0.00015	0.00043	CcSEcCtD
Efavirenz—Flushing—Doxorubicin—uterine cancer	0.000149	0.000428	CcSEcCtD
Efavirenz—Cardiac disorder—Doxorubicin—uterine cancer	0.000149	0.000428	CcSEcCtD
Efavirenz—Flatulence—Epirubicin—uterine cancer	0.000149	0.000427	CcSEcCtD
Efavirenz—Tension—Epirubicin—uterine cancer	0.000148	0.000425	CcSEcCtD
Efavirenz—Dysgeusia—Epirubicin—uterine cancer	0.000148	0.000425	CcSEcCtD
Efavirenz—Nervousness—Epirubicin—uterine cancer	0.000147	0.000421	CcSEcCtD
Efavirenz—Back pain—Epirubicin—uterine cancer	0.000146	0.000419	CcSEcCtD
Efavirenz—Angiopathy—Doxorubicin—uterine cancer	0.000146	0.000418	CcSEcCtD
Efavirenz—Dizziness—Etoposide—uterine cancer	0.000145	0.000417	CcSEcCtD
Efavirenz—Immune system disorder—Doxorubicin—uterine cancer	0.000145	0.000416	CcSEcCtD
Efavirenz—Mediastinal disorder—Doxorubicin—uterine cancer	0.000145	0.000415	CcSEcCtD
Efavirenz—Arrhythmia—Doxorubicin—uterine cancer	0.000143	0.000412	CcSEcCtD
Efavirenz—Vision blurred—Epirubicin—uterine cancer	0.000142	0.000409	CcSEcCtD
Efavirenz—Alopecia—Doxorubicin—uterine cancer	0.000142	0.000407	CcSEcCtD
Efavirenz—Ill-defined disorder—Epirubicin—uterine cancer	0.00014	0.000402	CcSEcCtD
Efavirenz—Vomiting—Etoposide—uterine cancer	0.00014	0.000401	CcSEcCtD
Efavirenz—Erythema—Doxorubicin—uterine cancer	0.00014	0.000401	CcSEcCtD
Efavirenz—Malnutrition—Doxorubicin—uterine cancer	0.00014	0.000401	CcSEcCtD
Efavirenz—Anaemia—Epirubicin—uterine cancer	0.00014	0.000401	CcSEcCtD
Efavirenz—Agitation—Epirubicin—uterine cancer	0.000139	0.000398	CcSEcCtD
Efavirenz—Rash—Etoposide—uterine cancer	0.000139	0.000398	CcSEcCtD
Efavirenz—Dermatitis—Etoposide—uterine cancer	0.000138	0.000398	CcSEcCtD
Efavirenz—Headache—Etoposide—uterine cancer	0.000138	0.000395	CcSEcCtD
Efavirenz—Flatulence—Doxorubicin—uterine cancer	0.000138	0.000395	CcSEcCtD
Efavirenz—Tension—Doxorubicin—uterine cancer	0.000137	0.000394	CcSEcCtD
Efavirenz—Dysgeusia—Doxorubicin—uterine cancer	0.000137	0.000393	CcSEcCtD
Efavirenz—Malaise—Epirubicin—uterine cancer	0.000136	0.000391	CcSEcCtD
Efavirenz—Nervousness—Doxorubicin—uterine cancer	0.000136	0.00039	CcSEcCtD
Efavirenz—Vertigo—Epirubicin—uterine cancer	0.000136	0.00039	CcSEcCtD
Efavirenz—Syncope—Epirubicin—uterine cancer	0.000135	0.000389	CcSEcCtD
Efavirenz—Back pain—Doxorubicin—uterine cancer	0.000135	0.000388	CcSEcCtD
Efavirenz—Palpitations—Epirubicin—uterine cancer	0.000133	0.000383	CcSEcCtD
Efavirenz—Loss of consciousness—Epirubicin—uterine cancer	0.000133	0.000381	CcSEcCtD
Efavirenz—Cough—Epirubicin—uterine cancer	0.000132	0.000378	CcSEcCtD
Efavirenz—Vision blurred—Doxorubicin—uterine cancer	0.000132	0.000378	CcSEcCtD
Efavirenz—Convulsion—Epirubicin—uterine cancer	0.000131	0.000376	CcSEcCtD
Efavirenz—Nausea—Etoposide—uterine cancer	0.000131	0.000375	CcSEcCtD
Efavirenz—Hypertension—Epirubicin—uterine cancer	0.00013	0.000374	CcSEcCtD
Efavirenz—Ill-defined disorder—Doxorubicin—uterine cancer	0.00013	0.000372	CcSEcCtD
Efavirenz—Anaemia—Doxorubicin—uterine cancer	0.000129	0.000371	CcSEcCtD
Efavirenz—Myalgia—Epirubicin—uterine cancer	0.000129	0.000369	CcSEcCtD
Efavirenz—Chest pain—Epirubicin—uterine cancer	0.000129	0.000369	CcSEcCtD
Efavirenz—Arthralgia—Epirubicin—uterine cancer	0.000129	0.000369	CcSEcCtD
Efavirenz—Agitation—Doxorubicin—uterine cancer	0.000128	0.000369	CcSEcCtD
Efavirenz—Anxiety—Epirubicin—uterine cancer	0.000128	0.000368	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000128	0.000367	CcSEcCtD
Efavirenz—Discomfort—Epirubicin—uterine cancer	0.000127	0.000365	CcSEcCtD
Efavirenz—Malaise—Doxorubicin—uterine cancer	0.000126	0.000362	CcSEcCtD
Efavirenz—Dry mouth—Epirubicin—uterine cancer	0.000126	0.000361	CcSEcCtD
Efavirenz—Vertigo—Doxorubicin—uterine cancer	0.000126	0.00036	CcSEcCtD
Efavirenz—Syncope—Doxorubicin—uterine cancer	0.000125	0.00036	CcSEcCtD
Efavirenz—Confusional state—Epirubicin—uterine cancer	0.000124	0.000357	CcSEcCtD
Efavirenz—Palpitations—Doxorubicin—uterine cancer	0.000123	0.000355	CcSEcCtD
Efavirenz—Loss of consciousness—Doxorubicin—uterine cancer	0.000123	0.000353	CcSEcCtD
Efavirenz—Cough—Doxorubicin—uterine cancer	0.000122	0.00035	CcSEcCtD
Efavirenz—Shock—Epirubicin—uterine cancer	0.000121	0.000348	CcSEcCtD
Efavirenz—Convulsion—Doxorubicin—uterine cancer	0.000121	0.000348	CcSEcCtD
Efavirenz—Nervous system disorder—Epirubicin—uterine cancer	0.000121	0.000347	CcSEcCtD
Efavirenz—Thrombocytopenia—Epirubicin—uterine cancer	0.000121	0.000346	CcSEcCtD
Efavirenz—Hypertension—Doxorubicin—uterine cancer	0.000121	0.000346	CcSEcCtD
Efavirenz—Tachycardia—Epirubicin—uterine cancer	0.00012	0.000345	CcSEcCtD
Efavirenz—Skin disorder—Epirubicin—uterine cancer	0.00012	0.000344	CcSEcCtD
Efavirenz—Hyperhidrosis—Epirubicin—uterine cancer	0.000119	0.000342	CcSEcCtD
Efavirenz—Chest pain—Doxorubicin—uterine cancer	0.000119	0.000342	CcSEcCtD
Efavirenz—Myalgia—Doxorubicin—uterine cancer	0.000119	0.000342	CcSEcCtD
Efavirenz—Arthralgia—Doxorubicin—uterine cancer	0.000119	0.000342	CcSEcCtD
Efavirenz—Anxiety—Doxorubicin—uterine cancer	0.000119	0.00034	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000118	0.000339	CcSEcCtD
Efavirenz—Discomfort—Doxorubicin—uterine cancer	0.000117	0.000337	CcSEcCtD
Efavirenz—Anorexia—Epirubicin—uterine cancer	0.000117	0.000337	CcSEcCtD
Efavirenz—Dry mouth—Doxorubicin—uterine cancer	0.000116	0.000334	CcSEcCtD
Efavirenz—Confusional state—Doxorubicin—uterine cancer	0.000115	0.00033	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000112	0.000322	CcSEcCtD
Efavirenz—Shock—Doxorubicin—uterine cancer	0.000112	0.000322	CcSEcCtD
Efavirenz—Nervous system disorder—Doxorubicin—uterine cancer	0.000112	0.000321	CcSEcCtD
Efavirenz—Thrombocytopenia—Doxorubicin—uterine cancer	0.000112	0.000321	CcSEcCtD
Efavirenz—Insomnia—Epirubicin—uterine cancer	0.000111	0.00032	CcSEcCtD
Efavirenz—Tachycardia—Doxorubicin—uterine cancer	0.000111	0.00032	CcSEcCtD
Efavirenz—Skin disorder—Doxorubicin—uterine cancer	0.000111	0.000318	CcSEcCtD
Efavirenz—Paraesthesia—Epirubicin—uterine cancer	0.000111	0.000318	CcSEcCtD
Efavirenz—Hyperhidrosis—Doxorubicin—uterine cancer	0.00011	0.000317	CcSEcCtD
Efavirenz—Dyspnoea—Epirubicin—uterine cancer	0.00011	0.000315	CcSEcCtD
Efavirenz—Somnolence—Epirubicin—uterine cancer	0.00011	0.000315	CcSEcCtD
Efavirenz—Anorexia—Doxorubicin—uterine cancer	0.000109	0.000312	CcSEcCtD
Efavirenz—Dyspepsia—Epirubicin—uterine cancer	0.000108	0.000311	CcSEcCtD
Efavirenz—Decreased appetite—Epirubicin—uterine cancer	0.000107	0.000308	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000106	0.000305	CcSEcCtD
Efavirenz—Fatigue—Epirubicin—uterine cancer	0.000106	0.000305	CcSEcCtD
Efavirenz—Constipation—Epirubicin—uterine cancer	0.000105	0.000303	CcSEcCtD
Efavirenz—Pain—Epirubicin—uterine cancer	0.000105	0.000303	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000104	0.000298	CcSEcCtD
Efavirenz—Insomnia—Doxorubicin—uterine cancer	0.000103	0.000296	CcSEcCtD
Efavirenz—Paraesthesia—Doxorubicin—uterine cancer	0.000102	0.000294	CcSEcCtD
Efavirenz—Dyspnoea—Doxorubicin—uterine cancer	0.000102	0.000292	CcSEcCtD
Efavirenz—Feeling abnormal—Epirubicin—uterine cancer	0.000102	0.000292	CcSEcCtD
Efavirenz—Somnolence—Doxorubicin—uterine cancer	0.000101	0.000291	CcSEcCtD
Efavirenz—Gastrointestinal pain—Epirubicin—uterine cancer	0.000101	0.000289	CcSEcCtD
Efavirenz—Dyspepsia—Doxorubicin—uterine cancer	0.0001	0.000288	CcSEcCtD
Efavirenz—Decreased appetite—Doxorubicin—uterine cancer	9.91e-05	0.000285	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.84e-05	0.000283	CcSEcCtD
Efavirenz—Fatigue—Doxorubicin—uterine cancer	9.83e-05	0.000282	CcSEcCtD
Efavirenz—Urticaria—Epirubicin—uterine cancer	9.79e-05	0.000281	CcSEcCtD
Efavirenz—Constipation—Doxorubicin—uterine cancer	9.75e-05	0.00028	CcSEcCtD
Efavirenz—Pain—Doxorubicin—uterine cancer	9.75e-05	0.00028	CcSEcCtD
Efavirenz—Abdominal pain—Epirubicin—uterine cancer	9.74e-05	0.00028	CcSEcCtD
Efavirenz—Body temperature increased—Epirubicin—uterine cancer	9.74e-05	0.00028	CcSEcCtD
Efavirenz—Feeling abnormal—Doxorubicin—uterine cancer	9.39e-05	0.00027	CcSEcCtD
Efavirenz—Gastrointestinal pain—Doxorubicin—uterine cancer	9.32e-05	0.000268	CcSEcCtD
Efavirenz—Hypersensitivity—Epirubicin—uterine cancer	9.08e-05	0.000261	CcSEcCtD
Efavirenz—Urticaria—Doxorubicin—uterine cancer	9.06e-05	0.00026	CcSEcCtD
Efavirenz—Body temperature increased—Doxorubicin—uterine cancer	9.01e-05	0.000259	CcSEcCtD
Efavirenz—Abdominal pain—Doxorubicin—uterine cancer	9.01e-05	0.000259	CcSEcCtD
Efavirenz—Asthenia—Epirubicin—uterine cancer	8.84e-05	0.000254	CcSEcCtD
Efavirenz—Pruritus—Epirubicin—uterine cancer	8.72e-05	0.00025	CcSEcCtD
Efavirenz—Diarrhoea—Epirubicin—uterine cancer	8.43e-05	0.000242	CcSEcCtD
Efavirenz—Hypersensitivity—Doxorubicin—uterine cancer	8.4e-05	0.000241	CcSEcCtD
Efavirenz—Asthenia—Doxorubicin—uterine cancer	8.18e-05	0.000235	CcSEcCtD
Efavirenz—Dizziness—Epirubicin—uterine cancer	8.15e-05	0.000234	CcSEcCtD
Efavirenz—Pruritus—Doxorubicin—uterine cancer	8.07e-05	0.000232	CcSEcCtD
Efavirenz—Vomiting—Epirubicin—uterine cancer	7.83e-05	0.000225	CcSEcCtD
Efavirenz—Diarrhoea—Doxorubicin—uterine cancer	7.8e-05	0.000224	CcSEcCtD
Efavirenz—Rash—Epirubicin—uterine cancer	7.77e-05	0.000223	CcSEcCtD
Efavirenz—Dermatitis—Epirubicin—uterine cancer	7.76e-05	0.000223	CcSEcCtD
Efavirenz—Headache—Epirubicin—uterine cancer	7.72e-05	0.000222	CcSEcCtD
Efavirenz—Dizziness—Doxorubicin—uterine cancer	7.54e-05	0.000217	CcSEcCtD
Efavirenz—Nausea—Epirubicin—uterine cancer	7.32e-05	0.00021	CcSEcCtD
Efavirenz—Vomiting—Doxorubicin—uterine cancer	7.25e-05	0.000208	CcSEcCtD
Efavirenz—Rash—Doxorubicin—uterine cancer	7.19e-05	0.000206	CcSEcCtD
Efavirenz—Dermatitis—Doxorubicin—uterine cancer	7.18e-05	0.000206	CcSEcCtD
Efavirenz—Headache—Doxorubicin—uterine cancer	7.14e-05	0.000205	CcSEcCtD
Efavirenz—Nausea—Doxorubicin—uterine cancer	6.77e-05	0.000194	CcSEcCtD
